哥伦比亚抗治疗抑郁症的流行病学和负担:对TRAL研究的分析
Rodrigo Cordoba-Rojas1, Eugenio Ferro2, Lina Maria Agudelo Baena3
1Centro Rosarista de Salud Mental - CeRSaMe, Escuela de Medicina y Ciencias de la Salud - EMCS, Universidad del Rosario, Bogotá, Colombia.
Revista Colombiana de psiquiatria
|November 10, 2025
概括
抗治疗性抑郁症 (TRD) 影响了哥伦比亚30%以上的大型抑郁症 (MDD) 患者,严重影响生活和工作质量. 全面的心理健康计划对于管理这种负担至关重要.
科学领域:
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 大型抑郁症 (MDD) 在全球范围内构成了重大公共卫生挑战.
- 治疗耐药性抑郁症 (TRD) 代表了一大批MDD患者,结果较差.
- 了解哥伦比亚等多元人口中TRD的患病率和特征对于有针对性的干预至关重要.
研究的目的:
- 确定哥伦比亚成年MDD患者中TRD的患病率.
- 描述住院MDD患者的残疾,与健康相关的生活质量 (HRQoL) 和工作障碍.
- 确定与TRD相关的因素及其对患者功能影响.
主要方法:
- 一项涉及来自哥伦比亚四个中心的162名成年MDD患者的横截面研究.
- 使用DSM-5和MINI标准确认了MDD的诊断.
- 评估患者报告的结果,包括工作障碍 (WPAI:D),HRQoL (EQ-5D) 和残疾 (希恩残疾量表).
主要成果:
- 在哥伦比亚精神病学参考站点中,TRD的患病率估计为32.1%,在私立机构中明显更高.
- 很大一部分患者 (55%) 报告说平时活动中存在中度至严重的问题.
- 工作障碍严重,平均有53%的工作时间错过,总体工作障碍为67%. 在TRD患者中,工作和学校缺勤率较高.
- 虽然TRD患者的HRQoL较低,但非TRD患者的残疾和工作障碍较高.
结论:
- 哥伦比亚的精神疾病患病率很高,包括TRD,对HRQoL有很大的影响.
- 这些发现强调了需要增强和个性化的治疗方法,包括创新的治疗方法.
- 建议实施国家心理健康计划,以减轻这些疾病的负担.
相关概念视频
Depressive Disorders: Etiology
423
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
423
Antidepressant Drugs: MAOIs and Other Agents
784
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
784
Therapeutic Drug Monitoring: Affecting Factors
189
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
189
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Electroconvulsive Therapy
835
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
835


